Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if transurethral photodynamic therapy with
lemuteporfin has a therapeutic effect on lower urinary tract symptoms due to an enlarged
prostate.
Photodynamic therapy (known as "PDT") is a treatment that uses light to make a drug work.
This means the drug is "light-activated". Light-activated drugs do not work until a certain
color of light shines on the drug. When the drug and the light combine, they react together
to destroy tissue.
This study is investigating PDT with lemuteporfin as a possible treatment for an enlarged
prostate. PDT with lemuteporfin may destroy overgrown prostate tissue and help urinary
symptoms go back to normal.